Impact of Olanzapine on Productivity in Schizophrenia Treatment
Author Information
Author(s): Liu-Seifert Hong, Ascher-Svanum Haya, Osuntokun Olawale, Jen Kai Yu, Gomez Juan Carlos
Primary Institution: Lilly Research Laboratories
Hypothesis
Does olanzapine improve productivity levels in patients with schizophrenia compared to other antipsychotics?
Conclusion
Olanzapine treatment is associated with significantly greater improvements in productivity levels compared to some other antipsychotics in patients with schizophrenia.
Supporting Evidence
- Olanzapine-treated patients showed significantly higher productivity levels compared to those treated with risperidone and ziprasidone.
- Higher productivity levels were associated with lower symptom severity and better treatment persistence.
- First episode patients treated with olanzapine had better productivity outcomes than those treated with haloperidol.
Takeaway
This study found that patients with schizophrenia who took olanzapine were able to do more productive activities, like working or studying, compared to those who took other medications.
Methodology
Post hoc analysis of 6 randomized, double-blind clinical trials comparing productivity levels in patients treated with olanzapine versus other antipsychotics.
Potential Biases
The study's reliance on clinical trial data may introduce bias regarding generalizability to real-world settings.
Limitations
Findings are based on post hoc analysis and may not generalize to usual care settings.
Participant Demographics
Majority were male and Caucasian, with a mean age of approximately 36-41 years.
Statistical Information
P-Value
0.011, 0.008, 0.033, 0.026
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website